Testicular Cancer Patient Guide Table of Contents Urology Care Foundation Reproductive & Sexual Health Committee
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Prostate Cancer Causes, Risk Factors, and Prevention Risk Factors
cancer.org | 1.800.227.2345 Prostate Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that increases your chances of getting a disease such as cancer. Learn more about the risk factors for prostate cancer. ● Prostate Cancer Risk Factors ● What Causes Prostate Cancer? Prevention There is no sure way to prevent prostate cancer. But there are things you can do that might lower your risk. Learn more. ● Can Prostate Cancer Be Prevented? Prostate Cancer Risk Factors A risk factor is anything that raises your risk of getting a disease such as cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed. But having a risk factor, or even several, does not mean that you will get the disease. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Many people with one or more risk factors never get cancer, while others who get cancer may have had few or no known risk factors. Researchers have found several factors that might affect a man’s risk of getting prostate cancer. Age Prostate cancer is rare in men younger than 40, but the chance of having prostate cancer rises rapidly after age 50. About 6 in 10 cases of prostate cancer are found in men older than 65. Race/ethnicity Prostate cancer develops more often in African-American men and in Caribbean men of African ancestry than in men of other races. And when it does develop in these men, they tend to be younger. -
Testicular Germ Cell Tumors in Men with Down's Syndrome
Central Annals of Mens Health and Wellness Bringing Excellence in Open Access Research Article *Corresponding author Jue Wang, Director of Genitourinary Oncology Section, University of Arizona Cancer Center at Dignity Health Testicular Germ Cell St. Joseph’s, Phoenix, AZ, 625 N 6th Street, Phoenix, AZ 85004, Tel: 1602-406-8222; Email: Tumors in Men with Down’s Submitted: 23 March 2018 Accepted: 29 March 2018 Syndrome: Delayed Diagnosis, Published: 31 March 2018 Copyright Comorbidities May Contribute © 2018 Wang et al. OPEN ACCESS to the Suboptimal Outcome Keywords • Testicular germ cell tumor (TGCT) 1 2,3,4 Emma Weatherford and Jue Wang * • Down’s syndrome (DS) 1Baylor University, USA • Delayed diagnosis 2Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center, • Seminoma USA • Non seminomatous germ cell tumor; Orchiectomy 3 St. Joseph’s Hospital and Medical Center, USA • Chemotherapy 4Department of Genitourinary Oncology, University of Arizona Cancer Center at • Prognosis Dignity Health St. Joseph’s Hospital and Medical Center, USA Abstract Purpose: The main objective of this study was to determine the clinical features, treatment and prognosis of Down’s syndrome (DS) patients with testicular germ cell tumor (TGCT). Materials and methods: We conducted a pooled analysis of 43 Down’s syndrome patients diagnosed with TGCT published in literature between January 1985 and December 2016. Results: The median age was 30 years (range 2 – 50). A majority of tumors (67%) were seminomas. 26 (51%) patients were diagnosed as stage I, 14 (33%) and 7 (16%) as stage II and III, respectively. In the seminoma group, 18 patients (62%) were diagnosed with stage I, 9 (31%) with stage II and 2 (7%) with stage III. -
CASODEX (Bicalutamide)
HIGHLIGHTS OF PRESCRIBING INFORMATION • Gynecomastia and breast pain have been reported during treatment with These highlights do not include all the information needed to use CASODEX 150 mg when used as a single agent. (5.3) CASODEX® safely and effectively. See full prescribing information for • CASODEX is used in combination with an LHRH agonist. LHRH CASODEX. agonists have been shown to cause a reduction in glucose tolerance in CASODEX® (bicalutamide) tablet, for oral use males. Consideration should be given to monitoring blood glucose in Initial U.S. Approval: 1995 patients receiving CASODEX in combination with LHRH agonists. (5.4) -------------------------- RECENT MAJOR CHANGES -------------------------- • Monitoring Prostate Specific Antigen (PSA) is recommended. Evaluate Warnings and Precautions (5.2) 10/2017 for clinical progression if PSA increases. (5.5) --------------------------- INDICATIONS AND USAGE -------------------------- ------------------------------ ADVERSE REACTIONS ----------------------------- • CASODEX 50 mg is an androgen receptor inhibitor indicated for use in Adverse reactions that occurred in more than 10% of patients receiving combination therapy with a luteinizing hormone-releasing hormone CASODEX plus an LHRH-A were: hot flashes, pain (including general, back, (LHRH) analog for the treatment of Stage D2 metastatic carcinoma of pelvic and abdominal), asthenia, constipation, infection, nausea, peripheral the prostate. (1) edema, dyspnea, diarrhea, hematuria, nocturia, and anemia. (6.1) • CASODEX 150 mg daily is not approved for use alone or with other treatments. (1) To report SUSPECTED ADVERSE REACTIONS, contact AstraZeneca Pharmaceuticals LP at 1-800-236-9933 or FDA at 1-800-FDA-1088 or ---------------------- DOSAGE AND ADMINISTRATION ---------------------- www.fda.gov/medwatch The recommended dose for CASODEX therapy in combination with an LHRH analog is one 50 mg tablet once daily (morning or evening). -
U.S. Cancer Statistics: Male Urologic Cancers During 2013–2017, One of Three Cancers Diagnosed in Men Was a Urologic Cancer
Please visit the accessible version of this content at https://www.cdc.gov/cancer/uscs/about/data-briefs/no21-male-urologic-cancers.htm December 2020| No. 21 U.S. Cancer Statistics: Male Urologic Cancers During 2013–2017, one of three cancers diagnosed in men was a urologic cancer. Of 302,304 urologic cancers diagnosed each year, 67% were found in the prostate, 19% in the urinary bladder, 13% in the kidney or renal pelvis, and 3% in the testis. Incidence Male urologic cancer is any cancer that starts in men’s reproductive or urinary tract organs. The four most common sites where cancer is found are the prostate, urinary bladder, kidney or renal pelvis, and testis. Other sites include the penis, ureter, and urethra. Figure 1. Age-Adjusted Incidence Rates for 4 Common Urologic Cancers Among Males, by Racial/Ethnic Group, United States, 2013–2017 5.0 Racial/Ethnic Group Prostate cancer is the most common 2.1 Hispanic Non-Hispanic Asian or Pacific Islander urologic cancer among men in all 6.3 Testis Non-Hispanic American Indian/Alaska Native racial/ethnic groups. 1.5 Non-Hispanic Black 7.0 Non-Hispanic White 5.7 All Males Among non-Hispanic White and Asian/Pacific Islander men, bladder 21.8 11.4 cancer is the second most common and 29.4 kidney cancer is the third most Kidney and Renal Pelvis 26.1 common, but this order is switched 23.1 22.8 among other racial/ethnic groups. 18.6 • The incidence rate for prostate 14.9 cancer is highest among non- 21.1 Urinary Bladder 19.7 Hispanic Black men. -
Testicular Cancer Fact Sheet
SEXUAL HEALTH Testicular Cancer What You Should Know What is Testicular Cancer? • A feeling of weight in the testicles Testicular cancer happens when cells in the testicle grow to • A dull ache or pain in the testicle, scrotum or groin form a tumor. This is rare. More than 90 percent of testicular • Tenderness or changes in the male breast tissue cancers begin in the germ cells, which produce sperm. Learn how to do a testicular self-exam. Talk with your health There are two types of germ cell cancers (GCTs). Seminoma care provider as soon as you notice any of these signs. It’s can grow slowly and respond very well to radiation and common for men to avoid talking with their doctor about chemotherapy. Non-seminoma can grow more quickly and something like this. But don’t. The longer you delay, the can be less responsive to those treatments. There are a few more time the cancer has to spread. When found early, types of non-seminomas: choriocarcinomas, embryonal testicular cancer is curable. carcinomas, teratomas and yolk sac tumors. If you do have symptoms, your doctor should do a physical There are also rare testicular cancers that don’t form in the exam, an ultrasound and a tumor marker blood test. You germ cells. Leydig cell tumors form from the Leydig cells may be referred to a urologist for care. This is a surgeon that produce testosterone. Sertoli cell tumors arise from the who treats testicular cancer among other things. Sertoli cells that support normal sperm growth. Testicular cancer is not diagnosed with a standard biopsy The type of testicular cancer you have, your symptoms and (tissue sample) before surgery. -
Torsion of the Testicular Appendages in Adult Acute Scrotum
International Journal of Clinical Urology 2019; 3(2): 40-45 http://www.sciencepublishinggroup.com/j/ijcu doi: 10.11648/j.ijcu.20190302.13 ISSN: 2640-1320 (Print); ISSN: 2640-1355 (Online) Torsion of the Testicular Appendages in Adult Acute Scrotum Seiichi Saito Art Park Urology Hospital & Clinic, Sapporo, Japan Email address: To cite this article: Seiichi Saito. Torsion of the Testicular Appendages in Adult Acute Scrotum. International Journal of Clinical Urology. Vol. 3, No. 2, 2019, pp. 40-45. doi: 10.11648/j.ijcu.20190302.13 Received: August 28, 2019; Accepted: October 15, 2019; Published: October 26, 2019 Abstract: Adult patients with acute scrotum sometimes tend to be treated for epididymitis without undergoing ultrasonographic examination, although precise ultrasonography reveals that there are some patients with torsion of the testicular appendages. In this report, I investigate the incidence of patients with torsion of the testicular appendages among patients with adult acute scrotum, who mainly used to be treated for epididymitis. In the last 5 years, 46 patients (23~62, average age 43.5 years) with scrotal pain and swelling visited our clinic for diagnosis and treatment. On an outpatient basis, their symptoms were evaluated, and blood tests, urinalysis, and grey scale and color Doppler ultrasonography with a 5-12 MHz linear scan were performed. Five (10.9%) of the 46 patients were diagnosed as having torsion of the testicular appendages. Although none of them had a high fever, 4 of the 5 (80%) had nausea and abdominal pain. Leukocytosis and pyuria were not found in any case. Typical ultrasound appearances were reactive hydrocele and a hyperechoic swollen mass or enlarged hyperechoic, spherical mass of the appendage. -
What Is a Hydrocelectomy, Spermatocelectomy and Epididymal Cystectomy? a Hydrocele Is an Abnormal Fluid Collection Between the Outer Tissue Layers of the Testicle
Dr. Kevin G. Kwan, BSc (Hons), MD, FRCS(C) Minimally Invasive Surgery and General Urology Assistant Clinical Professor Division of Urology, Department of Surgery McMaster University Chief of Surgery, Milton District Hospital Georgetown Hospital • Milton District Hospital • Oakville Trafalgar Memorial Hospital Suite 205 - 311 Commercial Street • Milton • Ontario • L9T 3Z9 • Tel: (905) 875-3920 • Fax: (905) 875-4340 Email: [email protected] • Web: www.haltonurology.com What is a hydrocelectomy, spermatocelectomy and epididymal cystectomy? A hydrocele is an abnormal fluid collection between the outer tissue layers of the testicle. These tissue layers naturally secrete fluid and when this fluid is not reabsorbed, as it usually would be, a fluid collection or hydrocele forms. The cause of most hydroceles is unknown, although some may be related to trauma, infection, or past surgery. A spermatocele is a cyst-like sac that is usually attached to the epididymis, the tube that sits behind the testicle and stores sperm. The sac of a spermatocele is filled with sperm. The exact cause of a spermatocele is unknown but it is thought that injury and obstruction may play a part in their formation. An epididymal cyst is much the same as a spermatocele. However, the sac attached to the epididymis is a true cyst and is filled with cystic fluid and not sperm. A hydrocelectomy is an operation to treat a hydrocele. An incision is made in the scrotum and the testicle containing the hydrocele is lifted out. The sac is then removed and the remaining tissue edges are stitched back. The tissue edges then heal onto themselves and the surrounding vessels naturally reabsorb any fluid produced. -
What Is a Hydrocele?
What is a Hydrocele? There is little point in merely aspirating Liberal use of local anaesthetic will or withdrawing the fluid as the help to reduce pain after the It is a fluid filled sack along the hydrocele usually recurs. operation. spermatic cord within the scrotum. Hydroceles can occur on one or both The Hydrocele repair operation Any stitches will dissolve after 2 to 3 sides. weeks and should not need removal. Hydrocele repair surgery is a simple In children, fluid drains incorrectly procedure and the success rate is Risks of the operation through the open tract from the very high. The outcome is usually abdomen into the scrotum where it satisfactory. There is a slight risk of breathing becomes trapped causing problems and medication reactions in enlargement of the scrotum. This minor surgery is done as a day anaesthesia. Possible complications case using general or local of surgery include haematoma (blood Sometimes, and more commonly in anaesthesia with prompt recovery clot formation), infection or injury to older men, inflammation or trauma of expected. The procedure only rarely the scrotal tissue or structures. There the testis or epidymis can cause a requires a scrotal drainage tube or a is a small risk of recurrence. hydrocele. Occasionally, a hydrocele large bulky dressing to the scrotal may be associated with an inguinal area. At home hernia. Many occur for no obvious reason. How is it done? You will feel a little tired for a few days. Any local discomfort can be A hydrocele results in a painless, You will be anaesthetised and pain helped by your usual pain killers i.e. -
PROSTATE and TESTIS PATHOLOGY “A Coin Has Two Sides”, the Duality of Male Pathology
7/12/2017 PROSTATE AND TESTIS PATHOLOGY “A Coin Has Two Sides”, The Duality Of Male Pathology • Jaime Furman, M.D. • Pathology Reference Laboratory San Antonio. • Clinical Assistant Professor Departments of Pathology and Urology, UT Health San Antonio. Source: http://themoderngoddess.com/blog/spring‐equinox‐balance‐in‐motion/ I am Colombian and speak English with a Spanish accent! o Shannon Alporta o Lindsey Sinn o Joe Nosito o Megan Bindseil o Kandace Michael o Savannah McDonald Source: http://www.taringa.net/posts/humor/7967911/Sindrome‐de‐la‐ Tiza.html 1 7/12/2017 The Prostate Axial view Base Apex Middle Apex Sagittal view Reference: Vikas Kundra, M.D., Ph.D. , Surena F. Matin, M.D. , Deborah A. Kuban, M.Dhttps://clinicalgate.com/prostate‐cancer‐4/ Ultrasound‐guided biopsy following a specified grid pattern of biopsies remains the standard of care. This approach misses 21% to 28% of prostate cancers. JAMA. 2017;317(24):2532‐2542. http://www.nature.com/nrurol/journal/v10/n12/abs/nrurol.2013.195.html Prostate Pathology Inflammation / granulomas Categories Adenosis, radiation, atrophy seminal vesicle Biopsy Benign TURP HGPIN Unsuspected carcinoma is seen in 12% of Atypical IHC TURP cases. glands Prostatectomy Subtype, Gleason, Malignant fat invasion, vascular invasion Other malignancies: sarcomas, lymphomas Benign Prostate Remember Malignant Glands Lack Basal Glands Cells Basal cells Secretory cells Stroma 2 7/12/2017 Benign Prostatic Lesions Atrophy Corpora amylacea (secretions) Seminal Vesicle Acute inflammation GMS Basal cell hyperplasia Basal cell hyperplasia Granulomas (BPH) (BPH) coccidiomycosis Mimics of Prostate Carcinoma Atrophy. Benign Carcinoma with atrophic features Prostate Carcinoma 1. Prostate cancer is the most common, noncutaneous cancer in men in the United States. -
Ovarian Cancer Causes, Risk Factors, and Prevention Risk Factors
cancer.org | 1.800.227.2345 Ovarian Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for ovarian cancer. ● Ovarian Cancer Risk Factors ● What Causes Ovarian Cancer? Prevention There is no known way to prevent most ovarian cancers. But there are things you can do that might lower your risk. Learn more. ● Can Ovarian Cancer Be Prevented? Ovarian Cancer Risk Factors A risk factor is anything that increases your chance of getting a disease like cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed. But having a risk factor, or even many, does not mean that you will get the disease. And 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 some people who get the disease may not have any known risk factors. Researchers have discovered several risk factors that might increase a woman's chance of developing epithelial ovarian cancer. These risk factors don’t apply to other less common types of ovarian cancer like germ cell tumors and stromal tumors. Factors that increase your risk of ovarian cancers Getting older The risk of developing ovarian cancer gets higher with age. Ovarian cancer is rare in women younger than 40. Most ovarian cancers develop after menopause. Half of all ovarian cancers are found in women 63 years of age or older. Being overweight or obese Obesity has been linked to a higher risk of developing many cancers. -
Effects of Hydrocele on Morphology and Function of Testis
OriginalReview ArticleArticle Effects of Hydrocele on Morphology and Function of Testis Bader Aldoah1 and Rajendran Ramaswamy2* 1Department of Surgery, University of Najran, Saudi Arabia; 2Department of Pediatric and Neonatal Surgery, Maternity and Children’s Hospital (MCH) (Under Ministry of Health), Najran, Saudi Arabia Corresponding author: Abstract Rajendran Ramaswamy, Department of Pediatric and Neonatal Surgery, Hydrocele is generally believed as innocent. But there is increasing evidence of noxious Maternity and Children’s Hospital influences of hydrocele on testis resulting in morphological, structural and functional (MCH) (Under Ministry of Health), Najran, Saudi Arabia, consequences. These effects are due to increased intrascrotal pressure and higher Tel: +966 536427602; Fax: temperature-exposure of the testis. Increased intrascrotal pressure can cause testicular 0096675293915; E-mail: [email protected] dysmorphism and even testicular atrophy. The testicular dysmorphism is reversible by early hydrocele surgery, but when persist, possibly indicate negative influence on future spermatogenesis. Spermatic cord compression by hydrocele is responsible for testicular volume increase. Such testes lose 15%-21% volume after hydrocele surgery. Tense scrotal hydrocele can cause acute scrotal pain from testicular compartment syndrome, which is relieved by evacuation of hydrocele. Higher resistivity index of subcapsular artery of testis and higher elasticity index of testicular tissue are caused by large hydrocele. As an aftermath, testis suffers ischaemia with long-term effect on spermatogenesis. High pressure of hydrocele along with ischaemia and oedema is found to result in histopathological damage to testis like total/partial arrest of spermatogenesis, small seminiferous tubules, disorganized spermatogenetic cells, basement membrane thickening and low fertilty index in children. Higher temperature exposure of testis interferes with spermatogenesis. -
Prognostic Factors in Prostate and Testis Cancer J.P
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Erasmus University Digital Repository BJU International (1999), 83, 910–917 Prognostic factors in prostate and testis cancer J.P. VAN BRUSSEL and G.H.J. MICKISCH Department of Urology, Erasmus University and Academic Hospital Rotterdam, Rotterdam, the Netherlands pathological examination of resected specimens [4]. This Introduction creates uncertainty and controversy about the compara- The medical management of patients with prostate or tive eBcacy of diCerent treatments and expected out- testis cancer is based on knowledge of the biological comes for patients. Standardization of staging procedures behaviour of these malignancies, as well as factors such after radical prostatectomy (RP) and clearly defining the as the patient’s age and general medical condition. extraprostatic extension and positive surgical margins Depending on the expected prognosis, a patient may be will result in significant improvements in staging. treated with curative intent, at times enduring consider- Additional data to enhance the accuracy of staging and able morbidity from the treatment. In other cases, a prediction of clinical outcome for individual patients palliative approach, based on quality-of-life issues, may may include; systematic biopsies to predict preoperative be the treatment of first choice. It is a challenging task tumour volume and a volume-based prognostic index, to choose the optimal therapy for an individual patient linking cancer volume with extraprostatic extension, because of diBculties in predicting precisely the course seminal vesicle invasion and lymph node metastases [5]. of the malignant process in each patient. Studies on A multiple prognostic index [6], including variables such tissue-related prognostic factors form an extensive part as serum PSA, tumour volume, tumour grade, tumour of the contemporary oncological literature.